This inventor holds 22 USPTO granted patents and 8 published patent applications and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation, Glaxosmithkline LLC. Active years: 2005-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hertfordshire, GB (2005)
- Stevenage, Hartfordshire, GB (2007)
- Stevenage, GB (2006 - 2016)
Company Filing History:
15 out of 1,169 
5 out of 2,198 
1 out of 358 
Years Active: 2005-2016
Areas of Expertise:
Title: Andrew McMurtrie Mason: A Pioneer in Pharmaceutical Innovations
Introduction
Andrew McMurtrie Mason, a prolific inventor based in Stevenage, GB, has made significant contributions to the field of pharmaceuticals, evidenced by his impressive portfolio of 21 patents. His work primarily focuses on developing novel compounds that hold promise in medical applications.
Latest Patents
Among his latest innovations are compounds described by the formula (I), where R represents 2-indanyl, 1-methylpropyl, or a 2,6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl group. These patents detail configurations where R represents methyl, hydrogen, or in combination with the nitrogen atom attached, represent morpholino and its pharmaceutically acceptable derivatives. The implications of these compounds are particularly notable for their use as oxytocin antagonists, showcasing Mason’s focus on transformative medical solutions.
Career Highlights
Throughout his career, Mason has worked with prominent companies such as Glaxo Group Limited and SmithKline Beecham Corporation. His roles within these organizations have enabled him to leverage his expertise in the pharmaceutical industry to drive innovation and advance research initiatives.
Collaborations
Mason's contributions have been enriched through collaboration with esteemed colleagues, including Alan D. Borthwick and Chuen Chan. Their joint efforts have been instrumental in exploring new frontiers in medical chemistry and further enhancing the quality of Mason's inventions.
Conclusion
Andrew McMurtrie Mason's relentless pursuit of innovation in pharmaceuticals is reflected in his substantial number of patents and impactful collaborations. His work not only emphasizes the importance of research and development in healthcare but also highlights the crucial role of inventors in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile